Acurx Pharmaceuticals ACXP Ratios (2021-2026)

NASDAQ ACXP
$1.14 +0.00 (+0.44%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Acurx Pharmaceuticals Quarterly Ratios

Periods 22 quarters
Latest Jun 2026

Acurx Pharmaceuticals ratios data for the quarter ended Jun 2026. These financial ratios cover 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets AverageAssets Avg.
16.21M14.12M12.29M10.29M10.10M10.16M8.38M8.31M8.20M7.43M8.41M7.84M6.28M4.92M4.33M5.48M6.13M6.90M8.61M10.26M
Equity AverageEquity Avg.
14.90M13.34M11.55M9.74M9.27M8.54M6.31M5.76M5.08M4.30M5.33M4.71M3.05M1.64M1.46M2.94M3.60M4.45M6.14M7.58M
Valuation
Price to BookP/B
3.653.563.154.433.566.337.605.544.9611.876.4410.5011.9622.543.783.412.120.711.440.89
Enterprise Value
37.59M31.18M22.58M29.81M24.17M37.17M33.21M25.32M12.46M47.94M29.68M29.63M26.10M10.16M4.09M6.10M1.82M-3.82M0.79M-3.44M
Market Capitalization
52.05M44.14M33.66M38.90M34.78M46.28M40.38M34.46M19.51M55.41M38.60M35.99M31.86M13.86M8.74M12.16M7.72M3.73M10.09M7.26M
Return Ratios
Return on Capital Employed [ROCE]ROCE
-648.63%-348.31%-253.01%-180.77%-125.35%-103.22%
Return on Assets [ROA]ROA
-274.13%-182.41%-149.56%-115.50%-87.04%-73.14%
Return on Equity [ROE]ROE
-811.50%-340.23%-254.60%-178.91%-122.11%-98.99%

Acurx Pharmaceuticals Ratios API

Pull Acurx Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ACXP&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY